Close Close
Popular Financial Topics Discover relevant content from across the suite of ALM legal publications From the Industry More content from ThinkAdvisor and select sponsors Investment Advisor Issue Gallery Read digital editions of Investment Advisor Magazine Tax Facts Get clear, current, and reliable answers to pressing tax questions
Luminaries Awards
ThinkAdvisor

Life Health > Life Insurance > Term Insurance

Long-Term Care Insurance Still in Investors' Doghouse: Morgan Stanley

X
Your article was successfully shared with the contacts you provided.

One takeaway from a recent Morgan Stanley analyst review of the life and annuity market is that stand-alone long-term care insurance (LTCI) is still in the Wall Street doghouse.

(Related: Long-Distance Caregiving, Up Close: LTCI Insider)

A team led by Nigel Dally based the report on what analysts from the firm have been hearing from life insurance investors.

The investors themselves may eventually need long-term care services, or to provide care for an elderly friend or relative, but they are not especially sympathetic to insurers’ efforts to figure out how to turn financing care into a commercial product.

The Morgan Stanley analysts cited “details around long-term care exposure” as a top investor concern.

Executives from Ameriprise, for example, have talked at length about how that company manages its closed block of LTCI policies and why managers believe the capital needs of that block will have no effect on shareholders.

In spite of those assurances, “investors remain concerned that long-term care exposures will negatively impact capital management plans,” the Morgan Stanley analysts write.

The analysts also looked at the idea that a company like General Electric might be able to make a deal to transfer LTCI risk to another entity.

“From our perspective, there appears to be limited appetite for legacy long-term care operations from traditional reinsurers,” the analysts write.” Perhaps at a certain price something could be completed, and there is the possibility non-traditional players could also have some interest.”

The long duration of the policies and uncertainty about claims make assessing the possibility of a company making non-traditional deals difficult, the analysts write.

— Read also, on ThinkAdvisor:

— Connect with ThinkAdvisor Life/Health on Facebook and Twitter.


NOT FOR REPRINT

© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.


NOT FOR REPRINT

© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.


NOT FOR REPRINT

© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.